Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$114.4K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
3.24%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$204.5K
Q3 2024
Cash
Q3 2024
P/E
-17.24
Nov 11, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Selling, General & Admin $120.5K $179.9K $830.1K $1.983M $1.006M $1.155M $454.0K $1.217M $939.3K $1.139M
YoY Change -33.0% -78.33% -58.14% 97.09% -12.86% 154.32% -62.71% 29.61% -17.54%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $2.267K $9.365K $11.79K $13.37K $14.74K $12.54K $7.150K $7.150K $6.960K $0.00 $0.00 $0.00
YoY Change -100.0% -75.79% -20.6% -11.79% -9.29% 17.54% 75.38% 0.0% 2.73%
% of Gross Profit
Operating Expenses $120.5K $182.2K $839.4K $1.995M $1.019M $1.169M $466.5K $1.225M $946.5K $1.146M
YoY Change -33.84% -78.3% -57.92% 95.67% -12.82% 150.65% -61.9% 29.38% -17.42%
Operating Profit -$120.5K -$182.2K -$839.4K -$1.995M
YoY Change -33.84% -78.3% -57.92%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Interest Expense -$5.000K $1.000K $14.32K -$17.40K -$19.44K $4.044M $10.88M -$7.938M -$46.61K
YoY Change -600.0% -182.31% -10.49% -100.48% -62.83% -237.03% 16930.12%
% of Operating Profit
Other Income/Expense, Net $500.00 $500.00
YoY Change 0.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Pretax Income -$125.5K -$130.2K $215.8K $522.3K -$1.037M -$1.189M $3.577M $9.652M -$8.884M -$1.193M
YoY Change -3.57% -160.31% -58.68% -150.38% -12.78% -133.23% -62.94% -208.65% 644.86%
Income Tax $0.00 $100.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$125.5K -$130.2K -$830.1K -$2.009M -$1.037M -$1.189M $3.577M $9.652M -$8.884M -$1.193M
YoY Change -3.57% -84.32% -58.68% 93.76% -12.79% -133.24% -62.94% -208.65% 644.86%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 -$0.01 -$0.04
Diluted Earnings Per Share $0.00 $0.00 -$0.01 -$0.04 -$22.76K -$28.45K $49.78K $128.6K -$251.0K -$36.38K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Cash & Short-Term Investments $6.810K $73.20K $11.68K $188.5K $7.080K $167.5K $351.0K $12.45K $30.90K $56.27K $10.00K $0.00 $0.00
YoY Change -90.7% 526.71% -93.8% 2562.57% -95.77% -52.28% 2719.6% -59.71% -45.09% 462.7%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $6.650K $6.350K $0.00 $349.0K $6.880K $218.7K $9.170K $0.00 $14.81K $115.9K $20.00K $60.00K $0.00
YoY Change 4.72% -100.0% 4972.97% -96.85% 2285.06% -100.0% -87.22% 479.25% -66.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.46K $79.55K $11.68K $537.5K $13.96K $386.2K $360.2K $12.45K $45.72K $172.1K $30.00K $60.00K $0.00
YoY Change -83.08% 581.08% -97.83% 3750.43% -96.39% 7.22% 2793.25% -72.77% -73.44% 473.73% -50.0%
Property, Plant & Equipment $0.00 $10.49K $19.61K $31.82K $36.79K $46.51K $23.08K $30.23K $37.38K $40.00K $20.00K $0.00
YoY Change -100.0% -46.51% -38.37% -13.51% -20.9% 101.52% -23.65% -19.13% -6.55% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $20.00K $40.00K $0.00
YoY Change -100.0% -50.0%
Total Long-Term Assets $0.00 $0.00 $10.48K $19.62K $31.82K $36.79K $46.51K $23.08K $30.23K $40.94K $70.00K $50.00K $0.00
YoY Change -100.0% -46.59% -38.34% -13.51% -20.9% 101.52% -23.65% -26.16% -41.51% 40.0%
Total Assets $13.46K $79.55K $22.16K $557.1K $45.78K $423.0K $406.7K $35.53K $75.95K $213.1K $100.0K $110.0K $0.00
YoY Change
Accounts Payable $54.21K $41.57K $53.74K $46.05K $53.91K $9.780K $0.00 $5.070K $6.410K $0.00 $0.00 $10.00K $0.00
YoY Change 30.41% -22.65% 16.7% -14.58% 451.23% -100.0% -20.9% -100.0%
Accrued Expenses $6.000K $1.000K $100.8K $34.00K $132.2K $123.7K $88.41K $70.08K $52.64K $36.73K $20.00K $10.00K $0.00
YoY Change 500.0% -99.01% 196.41% -74.28% 6.92% 39.86% 26.16% 33.13% 43.32% 83.65% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $100.0K $0.00 $0.00 $230.1K $230.1K $230.1K $315.9K $211.8K $230.1K $200.0K $140.0K $0.00
YoY Change 0.0% -100.0% 0.0% 0.0% -27.16% 49.17% -7.97% 15.05% 42.86%
Long-Term Debt Due $0.00 $10.96K $9.400K $0.00
YoY Change -100.0% 16.6%
Total Short-Term Liabilities $160.2K $142.6K $154.5K $80.05K $416.2K $374.5K $327.9K $4.475M $15.30M $266.8K $220.0K $160.0K $0.00
YoY Change 12.37% -7.73% 93.03% -80.77% 11.14% 14.21% -92.67% -70.75% 5633.77% 21.29% 37.5%
Long-Term Debt $0.00 $0.00 $0.00 $9.380K $0.00 $0.00 $10.57K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00 $9.380K $0.00 $0.00 $10.57K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Liabilities $160.2K $142.6K $154.5K $89.43K $416.2K $374.5K $338.5K $4.475M $15.30M $266.8K $220.0K $160.0K $0.00
YoY Change 12.37% -7.73% 72.78% -78.51% 11.14% 10.64% -92.44% -70.75% 5633.77% 21.29% 37.5%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Basic Shares Outstanding 81.67M shares 79.95M shares 73.37M shares 54.51M shares
Diluted Shares Outstanding 81.67M shares 79.95M shares 73.37M shares 54.51M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.9717 Million

About Nu-Med Plus Inc

Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The firm is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.

Industry: Surgical & Medical Instruments & Apparatus Peers: